MAD2L1 and chronic myelogenous leukemia, BCR-ABL1 positive: The expression of the BCR::ABL oncogene, a hallmark of CML, is accompanied by reduced Bub1, Bub3, BubR1, and Mad2 expression resulting in mitotic checkpoint defects that lead to CIN in murine 32D cells15.